OK SB109

All health benefit plans offered, issued, or renewed in Oklahoma on or after November 1, 2025, must cover clinical genetic testing for inherited gene mutations associated with increased cancer risk when ordered by a health care provider and supported by medical evidence, including National Comprehensive Cancer Network (NCCN) Category 2A or higher recommendations.

Health benefit plans must cover evidence-based cancer imaging for individuals with increased cancer risk when recommended by a health care provider and supported by NCCN Category 2A or higher recommendations or other nationally recognized clinical practice guidelines.

Coverage for genetic testing and cancer imaging is exempt from annual deductibles, copayments, and coinsurance limits otherwise applicable to covered benefits.

For health savings accounts paired with high-deductible health plans, coverage applies after the enrollee satisfies the plan's minimum deductible, except for items or services classified as preventive care under federal tax code.

The act becomes effective November 1, 2025, and applies to the Oklahoma Employees Insurance Plan and all other health benefit plans in the state.